FREQUENCIES AND PREDICTORS OF THE LUPUS LOW DISEASE ACTIVITY STATE AND REMISSION IN TREATMENT-NAIVE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS - A REAL-WORLD COHORT STUDY

被引:0
|
作者
Gao, D. [1 ]
Hao, Y. [1 ]
Mu, L. [1 ]
Xie, W. [1 ]
Sun, X. [1 ]
Fan, Y. [1 ]
Ji, L. [1 ]
Zhang, Z. [1 ]
机构
[1] Peking Univ, Rheumatol & Clin Immunol Dept, Hosp 1, Beijing, Peoples R China
关键词
D O I
10.1136/annrheumdis-2020-eular.3041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OP0093
引用
收藏
页码:61 / 61
页数:1
相关论文
共 50 条
  • [21] Real-World Treatment Patterns in Patients with Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Aringer, Martin
    Arnaud, Laurent
    Furie, Richard A.
    Morand, Eric
    Peschken, Christine
    Desta, Barnabas
    Rapsomaniki, Eleni
    Hedberg, Jonatan
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Ghia, Canna
    Chen, Stephanie
    Ding, Bo
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1172 - 1174
  • [22] Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
    Kandane-Rathnayake, Rangi
    Golder, Vera
    Louthrenoo, Worawit
    Chen, Yi-Hsing
    Cho, Jiacai
    Lateef, Aisha
    Hamijoyo, Laniyati
    Luo, Shue-Fen
    Wu, Yeong-Jian J.
    Navarra, Sandra, V
    Zamora, Leonid
    Li, Zhanguo
    Sockalingam, Sargunan
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Hao, Yanjie
    Zhang, Zhuoli
    Basnayake, B. M. D. B.
    Chan, Madelynn
    Kikuchi, Jun
    Takeuchi, Tsutomu
    Bae, Sang-Cheol
    Oon, Sheeran
    O'Neill, Sean
    Goldblatt, Fiona
    Ng, Kristine
    Law, Annie
    Tugnet, Nicola
    Kumar, Sunil
    Tee, Cherica
    Tee, Michael
    Ohkubo, Naoaki
    Tanaka, Yoshiya
    Lau, Chak Sing
    Nikpour, Mandana
    Morand, Eric F.
    Hoi, Alberta
    Asia-Pacific Lupus Collaboration
    RHEUMATOLOGY, 2025,
  • [23] The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study
    Hu, Yinxiu
    Wang, Pengyu
    Cao, Xue
    Wu, Zhenbiao
    Feng, Yuan
    LUPUS, 2025, 34 (02) : 133 - 139
  • [24] LLDAS (LOW LUPUS DISEASE ACTIVITY STATE), LOW DISEASE ACTIVITY (LDA) AND REMISSION (ON- OR OFF-TREATMENT) PREVENT DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTINATIONAL MULTICENTER COHORT
    Ugarte-Gil, M. F.
    Hanly, J.
    Urowitz, M. B.
    Gordon, C.
    Bae, S. C.
    Romero-Diaz, J.
    Sanchez-Guerrero, J.
    Bernatsky, S.
    Clarke, A. E.
    Wallace, D. J.
    Isenberg, D.
    Rahman, A.
    Merrill, J. T.
    Fortin, P.
    Gladman, D. D.
    Bruce, I. N.
    Petri, M. A.
    Ginzler, E. M.
    Dooley, M. A.
    Ramsey-Goldman, R.
    Manzi, S.
    Jonsen, A.
    Van Vollenhoven, R.
    Aranow, C.
    Mackay, M.
    Ruiz-Irastorza, G.
    Lim, S. S.
    Inanc, M.
    Kalunian, K. C.
    Jacobsen, S.
    Peschken, C.
    Kamen, D. L.
    Askanase, A.
    Pons-Estel, B.
    Alarcon, G. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 177 - 178
  • [25] Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset
    Ciciriello, Sabina
    Littlejohn, Geoffrey
    O'Sullivan, Catherine
    Smith, Tegan
    Deakin, Claire T. T.
    CLINICAL RHEUMATOLOGY, 2023, 42 (11) : 2971 - 2980
  • [26] Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset
    Sabina Ciciriello
    Geoffrey Littlejohn
    Catherine O’Sullivan
    Tegan Smith
    Claire T. Deakin
    Clinical Rheumatology, 2023, 42 : 2971 - 2980
  • [27] BURDEN OF DISEASE AND REAL-WORLD TREATMENT PATTERNS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN THE AUSTRALIAN OPAL DATASET
    Littlejohn, Geoffrey
    Ciciriello, Sabina
    O'Sullivan, Catherine
    Smith, Tegan
    Deakin, Claire
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 18 - 18
  • [28] ATTAINMENT OF LUPUS LOW DISEASE ACTIVITY STATE EXCLUSIVE OF REMISSION IS PROTECTIVE AGAINST ADVERSE OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Kandane-Rathnayake, R.
    Golder, V.
    Louthrenoo, W.
    Chen, Y. H.
    Cho, J.
    Lateef, A.
    Hamijoyo, L.
    Luo, S. F.
    Wu, Y. J. Jan
    Navarra, S.
    Zamora, L.
    Li, Z.
    Sockalingam, S.
    Katsumata, Y.
    Harigai, M.
    Hao, Y.
    Zhang, Z.
    Basnayake, B.
    Chan, M.
    Kikuchi, J.
    Takeuchi, T.
    Oon, S.
    Bae, S. C.
    O'neill, S.
    Goldblatt, F.
    Ng, K.
    Law, A.
    Tugnet, N.
    Kumar, S.
    Tee, M.
    Tee, C.
    Tanaka, Y.
    Lau, C. S.
    Nikpour, M.
    Hoi, A.
    Morand, E. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 149 - 150
  • [29] Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus
    Tsang-A-Sjoe, Michel W. P.
    Bultink, Irene E. M.
    Heslinga, Maaike
    Voskuyl, Alexandre E.
    RHEUMATOLOGY, 2017, 56 (01) : 121 - 128
  • [30] BOTH PROLONGED REMISSION AND LUPUS LOW DISEASE ACTIVITY STATE ARE ASSOCIATED WITH REDUCED DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Tsang-A-Sjoe, M. W. P.
    Bultink, I. E. M.
    Heslinga, M.
    Voskuyl, A. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 771 - 771